Women With Valvular Heart Disease Less Likely to be Treated in Accordance With Guidelines than Men

European study of sex-related differences in the type and treatment of heart valve diseases published, with physician from Karl Landsteiner University of Health Sciences as corresponding author.
By: KL Krems
 
KREMS, Austria - Sept. 25, 2024 - PRLog -- In Europe, incidences of severe native valvular heart disease (VHD) and their treatment vary between men and women. This is the key finding of a comprehensive study conducted at more than 200 centres across Europe. Although numerous studies have reported on sex-specific differences in the treatment of heart attacks, very little data has been collected so far in relation to heart valve diseases. The findings of the latest study reveal that in the case of specific types of VHD, women are less likely than men to be treated in accordance with the recommendations applicable in Europe. In addition, the reasons for the failure to provide such treatment are different for men and women. Prof. Julia Mascherbauer, the corresponding author of the study, is a physician at Karl Landsteiner University of Health Sciences (KL Krems).

The incidence of severe native valvular heart disease is increasing rapidly as life expectancy in Europe continues to rise. At the same time, the treatment options available for VHD have improved significantly over the past few decades, which has mainly contributed to the introduction of new, minimally invasive forms of treatment. However, very little research has been conducted into sex-specific variations regarding the diagnosis and treatment of VHD. A new study has now addressed this situation: based on extensive data collected by the European Society of Cardiology (ESC), the study analysed sex-specific disparities in connection with the type of heart valve disease, the treatment administered, as well as reasons for the failure to provide treatment to female and male patients throughout Europe. In light of their significance, the findings were published in the Fast Track section of the European Heart Journal.

Scientific Contact

Prof. Dr. Julia Mascherbauer

Karl Landsteiner University of Health Sciences

Division of Internal Medicine 3
University Hospital St. Pölten

Dunant-Platz 1

3100 St. Pölten / Austria

T +43 2742 9004 - 12541

E julia.mascherbauer@stpoelten.lknoe.at

W https://www.kl.ac.at

Karl Landsteiner University of Health Sciences

Eva-Maria Gruber

Communications, PR & Marketing

Dr.-Karl-Dorrek-Straße 30

3500 Krems / Austria

T +43 2732 72090 231

M +43 664 5056211

E evamaria.gruber@kl.ac.at

W https://www.kl.ac.at/

Copy Editing & Distribution

PR&D – Public Relations for Research & Education

Dr. Barbara Bauder

Kollersteig 68

3400 Klosterneuburg / Austria

M +43 664 1576 350

E  bauder@prd.at

L https://www.linkedin.com/company/prd-public-relations-für-forschung-bildung (https://www.linkedin.com/company/prd-public-relations-f%C3%BCr-forschung-bildung)

W (https://www.kl.ac.at/) https://www.prd.at/

Contact
PR&D
***@prd.at
End
Source:KL Krems
Email:***@prd.at Email Verified
Tags:Heart
Industry:Health
Location:Krems - Lower Austria - Austria
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
PR&D - Public Releations for Research & Education PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share